Last reviewed · How we verify
NCT06803212
Investigation of Dual-Task Exercise's Effect in Parkinson's Disease
NA trial testing Conventional Physiotherapy Program in Parkinson Disease in 32 participants. Completed in 30 December 2024.
30 December 2024
Quick facts
| Lead sponsor | Emre Şenocak |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 28 June 2024 |
| Primary completion | 30 December 2024 |
| Estimated completion | 30 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Conventional Physiotherapy Program
- Dual-Task Interference
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
Emre Şenocak
Who can join
Adults 50 to 85, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to investigate the effects of dual-task training on upper extremity motor functions in patients with Parkinson's disease. A total of 32 patients participated in the study. Patients were divided into two groups by randomization. One group received only conventional physiotherapy applications, while the other group performed dual-task exercises in addition. Dual-task exercises were performed while conventional treatment was applied. The treatment program was applied as 60x5x6 min/day/week. Conventional treatment was determined according to the individual needs of the patients, including the lower and upper extremities. Dual-task interventions included performing such as counting backward, word recall, and reading words backward. Assessments were repeated twice: Baseline and after a 30-session. "Demographic Information", "Movement Disorder Society (MDS)-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)", "Box and Block Test" and "Parkinson Disease Questionnaire (PDQ-39) were used as assessment tools.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of dual-task interference on upper extremity motor experience with Parkinson's disease motor effect of dual-task in Parkinson's disease.
Şenocak E, Karaca S, Aktürk A. · · 2025 · PMID 41126101 · DOI 10.1186/s12883-025-04462-4
Verify or expand the search:
- PubMed search for NCT06803212
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Conventional Physiotherapy Program
Trials testing the same drug.
- NCT07525297 — Mulligan's Mobilization in Rotator Cuff Pathology · NA · not yet recruiting
- NCT07291310 — Virtual Reality and Dual-Task Training for Cortical Plasticity in Children With Brachial Plexus Injury · NA · not yet recruiting
- NCT07425301 — Comparing the Effects of Ischemic Compression and Kinesiology Taping Techniques · NA · completed
- NCT05925517 — The Effect of Graded Motor Imagery on Pain and Function in Individuals With Knee Osteoarthritis · NA · completed
- NCT05229393 — Manual Therapy to the Cervical Spine and Diaphragm Combined With Breathing Reeducation Exercises, in nsCNP Patients · NA · completed
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Emre Şenocak trials
Trials by the same sponsor.
- NCT07249619 — A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in ICU · NA · not yet recruiting
- NCT07167667 — Median Nerve Thickness of the Carpal Tunnel Syndrome After Two Different Physiotherapy Modalities · NA · recruiting
- NCT06490809 — Minimal Clinically Important Difference of the Box and Block Test in Parkinson · NA · recruiting
- NCT06580171 — Validation of Walking and Remembering Test · NA · completed
- NCT06485934 — Kinesiophobia Scale for the Upper Extremity · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06803212 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Emre Şenocak
- Last refreshed: 31 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06803212.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing